Display options
Cite
Kaufmann F, Lacoste C. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats. Diabetologia. 1986;29(3):175-80doi: 10.1007/BF02427089.
Kaufmann, F., & Lacoste, C. (1986). Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats. Diabetologia, 29(3), 175-80. https://doi.org/10.1007/BF02427089
Kaufmann, F, and Lacoste, C. "Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats." Diabetologia vol. 29,3 (1986): 175-80. doi: https://doi.org/10.1007/BF02427089
Kaufmann F, Lacoste C. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats. Diabetologia. 1986 Mar;29(3):175-80. doi: 10.1007/BF02427089. PMID: 3516774.
Copy Download .nbib Format: NLM
Share it on

Diabetologia. 1986 Mar;29(3):175-80. doi: 10.1007/BF02427089.

Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.

Diabetologia

F Kaufmann, C Lacoste

PMID: 3516774 DOI: 10.1007/BF02427089

Abstract

Vitreous fluorophotometry was performed on pigmented male rats (Piebald strain) 2 weeks after induction of diabetes by streptozotocin. In vivo fluorophotometry data were compared with measurements obtained by direct extraction of the vitreous 60 min after an intravenous injection of sodium fluorescein. In addition, the rate of fluorescein disappearance from blood plasma, plasma protein binding of fluorescein and the effect of insulin treatment of diabetic animals were investigated. Age-matched nondiabetic animals served as controls. In vivo fluorophotometric measurements showed a good correlation with fluorescein determinations after direct extraction of the vitreous. Vitreous fluorescein concentrations were similar in diabetic and normal rats and were strongly related to the dye plasma levels within each group of animals. In the diabetic rats, however, the elimination of plasma fluorescein was accelerated and the percentage of free fluorescein, as determined by ultrafiltration and equilibrium dialysis, was consistently higher (130-150% of controls). The ratios of vitreous to total or free plasma fluorescein levels were elevated in diabetic rats. Experimental data indicate that plasma concentration of free fluorescein is crucial for vitreous dye accumulation. Insulin treatment of diabetic rats markedly improved their metabolic state and normalized the plasma fluorescein elimination and the vitreous to plasma fluorescein concentration ratios. It is concluded that vitreous fluorophotometry can be adequately applied to pigmented rats, provided that plasma fluorescein elimination rate and protein binding are considered in the interpretation of the results, since both influence the vitreous fluorescein accumulation and both may be altered by disease and drug treatment.

References

  1. Arch Ophthalmol. 1980 Nov;98(11):2032-40 - PubMed
  2. Anal Biochem. 1969 Apr 4;28(1):307-12 - PubMed
  3. Arch Ophthalmol. 1980 Dec;98(12):2231-2 - PubMed
  4. Invest Ophthalmol Vis Sci. 1981 Dec;21(6):854-64 - PubMed
  5. Diabetologia. 1981 Oct;21(4):409-14 - PubMed
  6. Diabetes. 1982 Jan;31(1):80-5 - PubMed
  7. Invest Ophthalmol Vis Sci. 1983 Jan;24(1):57-65 - PubMed
  8. Am J Ophthalmol. 1979 Sep;88(3 Pt 1):342-5 - PubMed
  9. Arch Ophthalmol. 1984 Sep;102(9):1366-9 - PubMed
  10. Invest Ophthalmol Vis Sci. 1979 Nov;18(11):1185-90 - PubMed
  11. Invest Ophthalmol Vis Sci. 1985 May;26(5):764-8 - PubMed
  12. Int J Microcirc Clin Exp. 1983;2(3):207-13 - PubMed
  13. Br J Ophthalmol. 1975 Nov;59(11):649-56 - PubMed
  14. Ophthalmic Res. 1982;14(6):416-27 - PubMed
  15. J Pharmacol Exp Ther. 1962 Aug;137:141-7 - PubMed
  16. Retina. 1982;2(2):121-5 - PubMed
  17. Arch Ophthalmol. 1980 Apr;98(4):725-8 - PubMed
  18. Arch Ophthalmol. 1983 Jun;101(6):968-70 - PubMed
  19. Arch Ophthalmol. 1980 Dec;98(12):2235-7 - PubMed
  20. Arch Ophthalmol. 1978 May;96(5):812-4 - PubMed
  21. Int J Microcirc Clin Exp. 1983;2(3):191-7 - PubMed
  22. Int J Microcirc Clin Exp. 1983;2(3):199-205 - PubMed
  23. Drug Metab Rev. 1976;5(1):43-140 - PubMed
  24. Arch Ophthalmol. 1978 May;96(5):878-9 - PubMed

Substances

MeSH terms

Publication Types